TrueBlue, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TrueBlue, Inc. (NYSE: TBI) on April 13, 2026, covering events occurring on April 10, 2026. The filing details the entry into a Cooperation Agreement with significant shareholder Eric H. Su and his affiliated entities (collectively "EHS").
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder agreements rather than financial performance.
Material Changes and Agreements
- Cooperation Agreement: TrueBlue entered into an agreement with EHS to resolve governance matters.
- Board Appointment: The Board agreed to appoint a new independent director ("New Director") mutually selected by TrueBlue and EHS. Selection must occur by September 30, 2026.
- Term: The New Director's term will expire at the 2027 Annual Meeting of Shareholders.
- Shareholder Support: EHS agreed to support TrueBlue's slate of director nominees for the 2026 Annual Meeting.
- Replacement Provision: If the New Director cannot serve, TrueBlue and EHS must cooperate to select a replacement, provided EHS maintains a Net Long Position of at least 1.0% of outstanding shares.
- Standard Provisions: The agreement includes customary voting commitments, standstill provisions, non-disparagement clauses, and expense reimbursement terms.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, operational outlook, or specific risk factors beyond the standard legal contingencies inherent in the Cooperation Agreement. The agreement is subject to the full text of Exhibit 10.1.
Key Facts for Investor Verification
- Verify the identity of the "New Director" once selected by September 30, 2026.
- Confirm EHS's current Net Long Position to ensure it remains above the 1.0% threshold required for the replacement director provision.
- Review the full text of the Cooperation Agreement (Exhibit 10.1) for specific details on voting commitments and standstill limitations.
- Monitor the outcome of the 2026 Annual Meeting regarding the supported slate of director nominees.